Investor profile
Panakès Partners has backed 16 European tech companies across 19 funding rounds between 2016 and 2025, joining rounds totalling €468M. Most active in Healthtech and Robotics. Data as of 7 Aug 2026.
Also recorded as: Panakès · Panakes Partners
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| NanoPhoria | Italy | 1 | €84M |
| Complement Therapeutics | Germany | 1 | €72M |
| Salvia BioElectronics | Netherlands | 1 | €53M |
| Deepull | Spain | 1 | €50M |
| InnovHeart | Italy |
| Company | Stage | Amount | Date |
|---|---|---|---|
| NanoPhoria | Series A | €84M | 2025-10 |
| Complement Therapeutics | Series A | €72M | 2023-04 |
| Salvia BioElectronics | Series B | €53M | 2025-05 |
| Deepull |
| 1 |
| €49M |
| Vivasure Medical | Ireland | 2 | €38M |
| Enterprise Therapeutics | UK | 1 | €30M |
| Neuromod Devices | Ireland | 2 | €25M |
| Lymphatica Medtech | Switzerland | 1 | €18M |
| Alesi Surgical | Ireland | 2 | €12M |
| Diadem | Italy | 1 | €10M |
| Carthera | France | 1 | €9.0M |
| SamanTree Medical | Switzerland | 1 | €8.5M |
| Seventeen | Italy | 1 | €4.2M |
| Echolight | Italy | 1 | €4.0M |
| Endostart | Italy | 1 | €1.0M |
| Series C |
| €50M |
| 2025-04 |
| InnovHeart | Series C | €49M | 2022-01 |
| Enterprise Therapeutics | Series B | €30M | 2024-01 |
| Vivasure Medical | Other | €22M | 2022-05 |
| Lymphatica Medtech | Other | €18M | 2024-10 |
| Vivasure Medical | Series C | €16M | 2016-09 |
| Neuromod Devices | Other | €15M | 2023-04 |
